Glaxo Wellcome UK Ltd (t/a Allen & Hanburys) & Anor v Sandoz Ltd [2016] EWHC 1537 (Ch) (28 June 2016)

Glaxo Wellcome UK Ltd (t/a Allen & Hanburys) & Anor v Sandoz Ltd [2016] EWHC 1537 (Ch) (28 June 2016)

The Trade Mark is invalid because it does not satisfy Article 4 of the Trade Mark Regulation; it lacks sufficient clarity, precision, and uniformity. The description and visual representation together do not define a single sign but allow for multiple forms, which is impermissible under EU law. Therefore, the...

Source-derived case information.

Citation
[2016] EWHC 1537 (Ch)
Parties
Claimant: Glaxo Wellcome UK Limited (t/a Allen & Hanburys); Second Claimant: Glaxo Group Limited; Defendant: Sandoz Limited
Jurisdiction
England and Wales
Judgment Date
28 June 2016
Procedural Posture
Intellectual Property Trade Mark / Summary Judgment Application on Counterclaim for Invalidity and Dismissal of Infringement Claim
Outcome
Trade Mark declared invalid; infringement claim dismissed
Legal Topics
Trade Marks, Colour Marks, Graphical Representation, EU Trade Mark Regulation, Summary Judgment
Intellectual Property Law Trade Marks Colour Marks Graphical Representation EU Trade Mark Regulation Summary Judgment

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Downloadable case file Legal principles 4 Authorities cited 17 Party arguments 2
Sign in to unlock

Parties

Glaxo Wellcome UK Limited (t/a Allen & Hanburys)

Claimant

Glaxo Group Limited

Second Claimant

Sandoz Limited

Defendant

Procedural Posture

Intellectual Property Trade Mark / Summary Judgment Application on Counterclaim for Invalidity and Dismissal of Infringement Claim

  1. 1 Whether the Trade Mark (EU Trade Mark No. 3890126) is invalid for not conforming to Article 4 of Council Regulation (EC) 207/2009 (Trade Mark Regulation)
  2. 2 Whether the Trade Mark is a 'sign' and capable of being represented graphically
  3. 3 Whether the description and visual representation together provide sufficient clarity, precision, and uniformity

Ratio Decidendi

The Trade Mark is invalid because it does not satisfy Article 4 of the Trade Mark Regulation; it lacks sufficient clarity, precision, and uniformity. The description and visual representation together do not define a single sign but allow for multiple forms, which is impermissible under EU law. Therefore, the registration is invalid and the infringement claim fails.

Court Disposition

Trade Mark declared invalid; infringement claim dismissed

Orders

  • Declaration that EU Trade Mark No. 3890126 is invalid
  • Glaxo's claim for infringement of the Trade Mark is dismissed